Open Government Canada
Notice: Prescription Drug List (PDL): Triamcinolone acetonide
Published by Health Canada | Santé Canada
About this dataset
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide.